Centro de Atención Especializada, CAP Roger de Flor, Dreta de l'Eixample Barcelona, Roger de Flor 194, 08013, Barcelona, Spain.
Pituitary. 2012 Sep;15(3):380-5. doi: 10.1007/s11102-011-0331-2.
Neurosurgery is the most widely used definite treatment for pituitary tumors, while medical treatments are a good option to improve symptoms, which tend to recur when drugs are stopped. The aim of this study was to assess postsurgical morbidity of secreting pituitary adenomas (adrenocorticotropin hormone -ACTH- and growth hormone -GH- secreting) and non-functioning (NF) adenomas, operated between January 2002 and May 2009. We retrospectively reviewed the data of 94 patients who were operated by the same neurosurgeons and compared the immediate (1st month) and delayed (1st year) complications between the three groups of adenomas. Forty had immediate post-operative complications (42% of NF, 37% of GH-secreting and 48% of ACTH-secreting adenomas). The most frequent complications were transient diabetes insipidus (23%), cerebrospinal fluid leaks (7%), sinusitis and meningitis (2%). Patients with Cushing's disease showed a tendency to have more transient diabetes insipidus and sinusitis compared to NF adenomas (P = 0.071). Ten patients had delayed complications during the first post-operative year (7% of NF, 11% of GH-secreting and 15% of ACTH-secreting), with a greater incidence of arthromyalgias and acute carpal tunnel syndrome in ACTH-secreting adenomas, compared with the other groups (P < 0.05). We conclude, that although ACTH-secreting adenomas are mostly microadenomas (78%) and affect younger patients, they are associated with a greater number of immediate and delayed complications during the first postoperative year (mainly invalidating arthromyalgias and acute carpal tunnel syndrome) compared with larger GH-secreting and NF adenomas, probably related to acute glucocorticoid deprivation after successful surgery.
神经外科是治疗垂体瘤最常用的方法,而药物治疗则是改善症状的一种选择,停药后症状往往会复发。本研究旨在评估 2002 年 1 月至 2009 年 5 月期间由同一位神经外科医生手术的分泌性(促肾上腺皮质激素 -ACTH- 和生长激素 -GH- 分泌)和无功能(NF)腺瘤患者的术后发病率。我们回顾性分析了 94 例患者的数据,并比较了三组腺瘤的即刻(术后 1 个月)和迟发性(术后 1 年)并发症。有 40 例患者发生了即刻术后并发症(NF 组占 42%,GH 分泌性腺瘤占 37%,ACTH 分泌性腺瘤占 48%)。最常见的并发症是短暂性尿崩症(23%)、脑脊液漏(7%)、鼻窦炎和脑膜炎(2%)。与 NF 腺瘤相比,库欣病患者更易出现短暂性尿崩症和鼻窦炎(P = 0.071)。10 例患者在术后第一年出现迟发性并发症(NF 组占 7%,GH 分泌性腺瘤占 11%,ACTH 分泌性腺瘤占 15%),与其他两组相比,ACTH 分泌性腺瘤更易发生关节炎和急性腕管综合征(P < 0.05)。我们的结论是,尽管 ACTH 分泌性腺瘤多为微腺瘤(78%),且患者年龄较小,但与体积较大的 GH 分泌性腺瘤和 NF 腺瘤相比,它们在术后第一年更易发生即刻和迟发性并发症(主要是无效关节炎和急性腕管综合征),这可能与手术成功后急性糖皮质激素缺乏有关。